Maitake β-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 620-626

  Masuda, Yuki ^a   Inoue, Munechika ^a   Miyata, Ayu ^a   Mizuno, Shigeto ^a   Nanba, Hiroaki ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

glucan; Antitumor activity; Cisplatin; Grifola frondosa; Myelotoxicity; Nephrotoxicity

Indexed keywords

BETA GLUCAN; CISPLATIN; COLONY STIMULATING FACTOR 1; CREATININE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P40; INTERLEUKIN 12P70; MESSENGER RNA; ANTINEOPLASTIC AGENT; FUNGUS ANTIGEN; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW SUPPRESSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GRIFOLA; IMMUNOCOMPETENT CELL; KIDNEY TUBULE NECROSIS; LUNG METASTASIS; MACROPHAGE; MAITAKE; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN WEIGHT; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BONE MARROW; CANCER TRANSPLANTATION; CFU COUNTING; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; KIDNEY; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYTOTHERAPY; SECONDARY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, FUNGAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA-GLUCANS; BONE MARROW; CELL LINE, TUMOR; CISPLATIN; COLONY-FORMING UNITS ASSAY; COLORECTAL NEOPLASMS; CREATININE; DRUG SYNERGISM; FEMALE; GRIFOLA; INTERFERON-GAMMA; INTERLEUKIN-12; KIDNEY; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; ORGAN SIZE; PHYTOTHERAPY;

EID: 63549141633     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.02.005     Document Type: Article

References (33)

1. Rozencweig M., von Hoff D.D., Slavik M., and Muggia F.M. Cis-diamminedichloroplatinum (II). A new anticancer drug. Ann Intern Med 86 6 (1997) 803-812
2. Jenkins V.K., Perry R.R., and Goodrich W.E. Effects of Cis-diamminedichloroplatinum (II) on hematopoietic stem cells in mice. Exp Hematol 9 3 (1981) 281-287
3. Arany I., and Safirstein R.L. Cisplatin nephrotoxicity. Semin Nephrol 23 5 (2003) 460-464
4. Megyesi J., Safirstein R.L., and Price P.M. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101 4 (1998) 777-782
5. Tsuruya K., Ninomiya T., Tokumoto M., Hirakawa M., Masutani K., Taniguchi M., et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63 1 (2003) 72-82
6. Lau A.H. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int 56 4 (1999) 1295-1298
7. Ramesh G., and Reeves W.B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110 6 (2002) 835-842
8. Ramesh G., and Reeves W.B. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 285 4 (2003) F610-F618
9. Lu L.H., Oh D.J., Dursun B., He Z., Hoke T.S., Faubel S., et al. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J Pharmacol Exp Ther 324 1 (2008) 111-117
10. Faubel S., Lewis E.C., Reznikov L., Ljubanovic D., Hoke T.S., Somerset H., et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 322 1 (2007) 8-15
11. Chihara G., Hamuro J., Maeda Y., Arai Y., and Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res 30 (1970) 2776-2781
12. Tsukagoshi S., Hashimoto Y., Fujii G., Kobayashi H., Nomoto K., and Orita K. Krestin (PSK). Cancer Treat Rev 11 (1984) 131-155
13. Nanba H., Hamaguchi A., and Kuroda H. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull 35 (1987) 1162-1168
14. Kodama N., Harada N., and Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 90 (2002) 357-360
15. Kodama N., Komuta K., Sakai N., and Nanba H. Effects of D-Fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull 25 (2002) 1647-1650
16. Harada N., Kodama N., and Nanba H. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett 192 (2003) 181-187
17. Inoue A., Kodama N., and Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull 25 (2002) 536-540
18. Kodama N., Asakawa A., Inui A., Masuda Y., and Nanba H. Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa. Oncol Rep 13 (2005) 497-502
19. Kodama N., Murata Y., Asakawa A., Inui A., Hayashi M., Sakai N., et al. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition 21 (2005) 624-629
20. Lin H., She Y.H., Cassileth B.R., Sirotnak F., and Cunningham Rundles S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol 4 1 (2004) 91-99
21. Cui W., Taub D.D., and Gardner K. qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res 35 (2007) D805-D809
22. Wang X., and Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31 24 (2003) e154
23. Masuda Y., Murata Y., Hayashi M., and Nanba H. Inhibitory effect of MD-Fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells. Biol Pharm Bull 31 6 (2008) 1104-1108
24. Palma J.P., and Aggarwal S.K. Cisplatin and carboplatin-mediated activation of murine peritoneal macrophages in vitro: production of interleukin-1 alpha and tumor necrosis factor-alpha. Anticancer Drugs 6 2 (1995) 311-316
25. Son K., and Kim Y.M. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. Cancer Res 55 23 (1995) 5524-5527
26. Lin H., Cheung S.W., Nesin M., Cassileth B.R., and Cunningham-Rundles S. Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin Vaccine Immunol 14 1 (2007) 21-27
27. Patchen M.L., Liang J., Vaudrain T., Martin T., Melican D., Zhong S., et al. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor. Stem Cells 16 3 (1998) 208-217
28. Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., et al. Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol Immunol 50 9 (2006) 687-700
29. Hirano T., Akira S., Taga T., and Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 11 12 (1990) 443-449
30. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6 3 (1997) 315-325
31. Nishida M., Fujimoto S., Toiyama K., Sato H., and Hamaoka K. Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Biochem Biophys Res Commun 324 1 (2004) 341-347
32. Iwasaki M., Adachi Y., Minamino K., Suzuki Y., Zhang Y., Okigaki M., et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 16 3 (2005) 658-666
33. Nishida M., and Hamaoka K. How does G-CSF act on the kidney during acute tubular injury?. Nephron Exp Nephrol 104 4 (2006) e123-e128